The effects of converting to Dysport from other botulinum toxin type A formulations for treating cervical dystonia patients
Objective: To investigate whether Dysport increases waning time compared to other botulinum toxin type A (BoNT-A) formulations for cervical dystonia (CD) therapy. Background: BoNT-A injections…Cost-Analysis of the Use of IncobotulinumtoxinA and AbobotulinumtoxinA for the Treatment of Post-Stroke Upper Limb Spasticity Based on Recommended Dosing for Muscles and Clinical Patterns
Objective: To carry out a cost-analysis based on the respective recommended dosing per muscle using IncobotulinumtoxinA (INCO) and AbobotulinumtoxinA (ABO) for the treatment of post-stroke…Sustained Functional Benefits After a Single Injection with AbobotulinumtoxinA Using a 2mL Injection Volume in Adults with Cervical Dystonia
Objective: We present efficacy, patient-reported outcomes (PROs), and safety in adults with cervical dystonia (CD) at last available visit after a single abobotulinumtoxinA injection using…AbobotulinumtoxinA Using 2 mL Dilution Maintains Durable Functional Improvements Across Multiple Treatment Cycles
Objective: This open-label extension (OLE) study evaluated the long-term safety and efficacy of repeat treatment cycles of abobotulinumtoxinA using 2 mL dilution (NCT01753336). Background: Cervical…Efficacy and Safety of AbobotulinumtoxinA in Adults with Cervical Dystonia: Similar Results Between 1mL and 2mL Dilution Methods
Objective: To evaluate efficacy and safety of a single injection of abobotulinumtoxinA using 1-mL or 2-mL dilution in adults with CD. Background: AbobotulinumtoxinA is approved…A German-Austrian multicenter, non-interventional, prospective study for the treatment with abobotulinumtoxinA injections in naïve and previously treated patients suffering from cervical dystonia
Objective: In this prospective, multicenter, non-interventional study (NCT01840462) the primary objective was effectiveness of abobotulinumtoxinA in BoNT treatment-naïve and previously treated subjects after two injection…Saliva changes and the oral health in Parkinson´s disease
Objective: The aim of this study was to determine the risk of change in the oral microflora and oral health in PD patients. Background: Parkinson…Effect of early AbobotulinumtoxinA (Dysport®) use after stroke on the time to reach reinjection criteria: asymptomatic versus symptomatic patients
Objective: To determine if early post-stroke (within 12 weeks) abobotulinumtoxinA (aboBoNT-A;Dysport®) injections delay appearance or progression of upper limb symptomatic spasticity. Background: Muscle tone changes…Efficacy and Safety of a 2 mL Dilution of AbobotulinumtoxinA Compared With Placebo in Adult Patients With Cervical Dystonia
Objective: To determine the efficacy and safety of a 500 U/2 mL dilution of aboBoNT-A as compared to placebo in patients with cervical dystonia (CD).…Impact of injection interval on patient satisfaction in the routine treatment of cervical dystonia with abobotulinumtoxinA
Objective: Evaluate the impact of injection interval on patient satisfaction with abobotulinumtoxinA (AboBoNT-A; Dysport®) over 1 injection cycle in patients with cervical dystonia (CD). Background:…
Abstracts from the International Congress of Parkinson’s and Movement Disorders.